Skip to main content
Fig. 4 | Orphanet Journal of Rare Diseases

Fig. 4

From: Hepatic fibrosis: a manifestation of the liver disease evolution in patients with Ataxia-telangiectasia

Fig. 4

Median values of the controlled attenuation parameter (CAP) measurement between patients without (n = 17) and with significant hepatic fibrosis (n = 4). *Significance level by Student's t-test (a). Median CAP values between patients without (n = 7) and with ultrasound liver steatosis (n = 11). *Significance level of the Mann–Whitney U test (b)

Back to article page